BlogAlternatives

Best Viz.ai Alternatives in 2026

Looking for Viz.ai alternatives? We compare Deelo and 2 other Disease Analysis platforms on features, pricing, and ease of use.

Davaughn White·Founder
4 min read

Why Look for Viz.ai Alternatives?

Viz.ai is a strong Disease Analysis tool, but it is not the right fit for every business. Trade-offs buyers sometimes mention when shopping for alternatives: Narrow focus on acute care — limited chronic disease or screening use cases; No practice management, CRM, or business operations capabilities; Enterprise pricing model requires hospital-level contracts. If any of those resonate with your situation, you have options. Below we compare the strongest alternatives — starting with the one that replaces the most tools in a single platform.

1. Deelo — Best All-in-One Alternative

Deelo is not just a Disease Analysis tool — it is a full business platform with 50+ apps including CRM, invoicing, scheduling, field service, marketing automation, helpdesk, and more. Instead of replacing Viz.ai with another single-purpose tool, you replace your entire SaaS stack. Pricing starts at $19/seat/mo with a free tier for evaluation, and every app shares a unified data layer so customer info flows automatically between tools.

Why Deelo over Viz.ai

  • All-in-one: 50+ apps included vs. Viz.ai's single-purpose focus
  • Transparent pricing at $19/seat/mo — no per-feature add-ons or surprise overages
  • Unified data layer means contacts, deals, and invoices are connected across every app
  • AI assistant that automates tasks across your entire business operation
  • Free tier available for evaluation before committing

Try Deelo free

See how one platform replaces Viz.ai and the rest of your tool stack. No credit card required.

Start Free — No Credit Card

2. Aidoc

Aidoc is best suited for radiology departments seeking automated triage and prioritization of critical findings. Strengths commonly cited by buyers: FDA-cleared AI solutions across 15+ clinical use cases and body areas; Always-on radiology AI that runs in the background on every scan; Strong integration with existing PACS and radiology workflows. Pricing sits at Custom per-scan or annual licensing. Trade-offs buyers often mention: Radiology-focused AI — limited capabilities outside imaging analysis; No patient management, scheduling, CRM, or business operations tools.

3. Tempus

Tempus is best suited for oncology programs and research institutions focused on precision medicine and genomics. Strengths commonly cited by buyers: Massive clinical and molecular dataset for precision medicine insights; Genomic sequencing and biomarker analysis for targeted therapy matching; Strong partnerships with oncology centers and pharmaceutical companies. Pricing sits at Custom institutional pricing. Trade-offs buyers often mention: Primarily oncology and genomics focused — limited general diagnostic use; No practice management, scheduling, CRM, or business operations platform.

How to Choose the Right Alternative

The right Viz.ai alternative depends on your priorities. If you want the deepest Disease Analysis feature set, look at Aidoc. If you want to consolidate your SaaS stack and stop paying for separate CRM, invoicing, scheduling, and Disease Analysis tools, Deelo is the clear choice. Either way, most platforms offer free trials — take advantage of them before committing.

Viz.ai Alternatives FAQ

What is the best free alternative to Viz.ai?
Deelo offers a free tier with access to all 50+ apps, making it the most feature-complete free alternative to Viz.ai.
Can I import my Viz.ai data into Deelo?
Yes. Deelo supports CSV and bulk imports for contacts, deals, invoices, and work orders. Migration typically takes under a day.
Is Viz.ai still worth using in 2026?
Viz.ai remains a strong choice if hospital emergency departments and stroke centers needing real-time ai triage. However, if you are paying for multiple tools alongside Viz.ai, consolidating to an all-in-one platform like Deelo can save money and reduce complexity.

Explore More

Related Articles